Citation: Sa. Watson et Ad. Gilliam, G17DT - a new weapon in the therapeutic armoury for gastrointestinal malignancy, EXPERT OP B, 1(2), 2001, pp. 309-317
Citation: Df. Mcwilliams et al., Antibodies raised against the extracellular tail of the CCKB/gastrin receptor inhibit gastrin-stimulated signalling, REGUL PEPT, 99(2-3), 2001, pp. 157-161
Citation: Sa. Watson, Oncogenic targets of beta-catenin-mediated transcription in molecular pathogenesis of intestinal polyposis, LANCET, 357(9256), 2001, pp. 572-573
Authors:
Kenny, FS
Gee, JMW
Nicholson, RI
Ellis, IO
Morris, TM
Watson, SA
Bryce, RP
Robertson, JFR
Citation: Fs. Kenny et al., Effect of dietary GLA plus /-tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenografts, INT J CANC, 92(3), 2001, pp. 342-347
Citation: Sa. Watson et Am. Smith, Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis, CANCER RES, 61(2), 2001, pp. 625-631
Citation: Hm. Collins et al., Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase, BR J CANC, 84(12), 2001, pp. 1664-1670
Authors:
Smith, AM
Justin, T
Michaeli, D
Watson, SA
Citation: Am. Smith et al., Phase I/II study of G17-DT, an anti-gastrin immunogen, in advanced colorectal cancer, CLIN CANC R, 6(12), 2000, pp. 4719-4724
Authors:
Watson, SA
Robinson, KE
McWilliams, D
Michaeli, D
Smith, AM
Robinson, G
Citation: Sa. Watson et al., Transforming growth factor-A-mediated growth pathways in human gastro-intestinal cell lines in relation to the gastrin autocrine pathway, INT J CANC, 87(1), 2000, pp. 20-28
Citation: Am. Smith et Sa. Watson, Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence, GUT, 47(6), 2000, pp. 820-824
Authors:
Watson, SA
Clarke, PA
Morris, TM
Caplin, ME
Citation: Sa. Watson et al., Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumor, CANCER RES, 60(20), 2000, pp. 5902-5907
Authors:
Kumar, A
Collins, HM
Scholefield, JH
Watson, SA
Citation: A. Kumar et al., Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer, BR J CANC, 82(4), 2000, pp. 960-965
Authors:
Watson, SA
Michaeli, D
Morris, TM
Clarke, P
Varro, A
Griffin, N
Smith, A
Justin, T
Hardcastle, JD
Citation: Sa. Watson et al., Antibodies raised by Gastrimmune inhibit the spontaneous metastasis of a human colorectal tumour, AP5LV, EUR J CANC, 35(8), 1999, pp. 1286-1291
Authors:
Campbell, LM
Anderson, TJ
Parashchak, MR
Burke, CM
Watson, SA
Turbitt, ML
Citation: Lm. Campbell et al., A comparison of the efficacy of long-acting beta(2)-agonists: eformoterol via Turbohaler (R) and salmeterol via pressurized metered dose inhaler or Accuhaler (R), in mild to moderate asthmatics (vol 93, pg 370, 1999), RESP MED, 93(7), 1999, pp. NIL_10-244
Authors:
Campbell, LM
Anderson, TJ
Parashchak, MR
Burke, CM
Watson, SA
Turbitt, ML
Citation: Lm. Campbell et al., A comparison of the efficacy of long-acting beta(2)-agonists: eformoterol via Turbohaler (R) and salmeterol via pressurized metered dose inhaler or Accuhaler (R), in mild to moderate asthmatics, RESP MED, 93(4), 1999, pp. 236-244
Authors:
Caplin, ME
Clarke, P
Grimes, S
Dhillon, AP
Khan, K
Savage, K
Lewin, J
Michaeli, D
Pounder, RE
Watson, SA
Citation: Me. Caplin et al., Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopy, REGUL PEPT, 84(1-3), 1999, pp. 81-89
Authors:
Watson, SA
Michaeli, D
Grimes, S
Morris, TM
Varro, A
Clarke, PA
Smith, AM
Justin, TA
Hardcastle, JD
Citation: Sa. Watson et al., A comparison of an anti-gastrin antibody and cytotoxic drugs in the therapy of human gastric ascites in SCID mice, INT J CANC, 81(2), 1999, pp. 248-254
Authors:
Watson, SA
Morris, TM
Varro, A
Michaeli, D
Smith, AM
Citation: Sa. Watson et al., A comparison of the therapeutic effectiveness of gastrin neutralisation intwo human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth, GUT, 45(6), 1999, pp. 812-817
Authors:
Rohlff, C
Watson, SA
Morris, TM
Skelton, L
Jackman, AL
Page, MJ
Citation: C. Rohlff et al., A novel, orally administered nucleoside analogue, OGT 719, inhibits the liver invasive growth of a human colorectal tumor, C170HM2, CANCER RES, 59(6), 1999, pp. 1268-1272
Authors:
Watson, SA
Morris, TM
Collins, HM
Bawden, LJ
Hawkins, K
Bone, EA
Citation: Sa. Watson et al., Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA, BR J CANC, 81(1), 1999, pp. 19-23
Authors:
Jacobs, E
Watson, SA
Michaeli, D
Ellis, IO
Robertson, JFR
Citation: E. Jacobs et al., Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7human breast cancer xenografts, BR J CANC, 80(3-4), 1999, pp. 352-359